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Abstract: The oxidative stress induced by excessive synthesis of Reactive Oxygen Species (ROS) or 
reduced antioxidant synthesis, is involved in physiological processes (normal pregnancy) or pathological 
processes, some of them with a great echo in the field of medical practice. For this reason, there are deeply 
justified the more frequent attempts to use in practice the compounds with antioxidant potential in the 
prophylaxis and treatment of some diseases which involve oxidative stress. The authors have studied the 
alterations of the oxidative stress parameters, assessed by the measuring of serum lipid peroxides, in the same 
time with the total antioxidant capacity- hydrogen donors, in Wistar female rats during gestation. The 
determinations were made in the 21st day and they were compared with the ones of a group of animals which 
have received during pregnancy- week 1, week 2, week 3- by gavages one dose of Chitosan (0,5 
mg/animal/dose), a product known for its antioxidant capacity, and of a group of animals which received during 
pregnancy-week 1, week 2, week 3- one dose of Vitamin C (100 mg/animal/dose). After the results were 
analysed, it was concluded that during gestation there appears a significant increase of lipid peroxidation, but 
also of the antioxidant systems at the end of gestation, which confirms the involvement of oxidant/ antioxidant 
systems in normal pregnancy. In animals which received Chitosan during gestation or Vitamin C, respectively, 
there was a decrease of the oxidative stress parameters. 
 
INTRODUCTION 
 
 Reactive Species of Oxygen are involved in physiological processes(physical effort, 
pregnancy, altitude adaptation, ageing) as well as pathological processes, some of them with a 
great echo in medical practice, as a causing, determinative agent, or, most likely, 
accompanying and aggravating primary lesions. 
The pregnancy, even the physiological one, uncomplicated, is a process which favors 
the appearance of oxidative stress; the placenta contains cells rich in mitochondria and has a 
rich vascularisation, being exposed this way to high oxygen partial pressures. During 
pregnancy, there are hemodynamic alterations, increase of the oxygen consumption, 
metabolic alterations and also of the energetically substratum in different organs, including 
the feto-placentary barrier (Nemeth s.c., 2001). During pregnancy there are significant 
alterations of the oxidative stress parameters: increase of the level of thiol groups (reduced 
glutathione, a source which can be oxidized, resulting ROS), superoxide dismutase (SOD) 
and serum ceruloplasmin, suggesting the appearance of oxidative stress (Olinescu, 1994). 
In the second trimester of pregnancy, the lipid peroxidation is getting amplified, 
highlighted by the increase of lipid peroxides. In the same time, the synthesis of antioxidants 
is getting more intense, the scavengers of oxygen free radicals are increasing: glutathione, the 
activity of superoxide dismutase, catalase, glutathion-peroxidase and reductase. 
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ROS are the cause or the consequence of pathological processes and it must be known 
that they can be a way of tissue aggression in many diseases. There are deeply justified the 
more frequent attempts to use compounds with antioxidant effects in processes related to ROS 
pathology. Their retrenchment sau of the effects taht thney produce offers a potential worthy 
to use in profilaxy or therapy. 
Among the compounds with antioxidant effects, a less studied one is Chitosan, which, 
besides its antioxidant effects (Je s.c., 2006), also has important immunoadjuvant (Chen s.c., 
2004), antitumoral (Qi s.c., 2007) and haemostatic effects. 
Vitamin C is a natural antioxidant, non-enzymatic, which can inhibit ROS synthesis 
(Dejica, 2000). 
The authors' aim is to follow ROS dynamics, assessed by lipid peroxidation and the 
capacity of antioxidant systems, determined by hydrogen donors level (total antioxidant 
capacity) in animals during gestation, determining in the same time the effects of Chitosan 
and Vitamin C, administrated during gestation, on the oxidant/antioxidant systems. 
 
MATERIAL AND METHOD 
 
 The authors included in the study Wistar female rats, with a weight of 180-200 grams, 
which were divided in four groups: Group I- non-pregnant animals; Group II- pregnant 
animals (hormone-controlled beginning of gestation, controlled ovulation); Group III-animals 
which received during gestation-weeks 1, 2, 3, a unique dose of Chitosan (0,5 
mg/animal/dose), administered by gavages; Group IV- animals which received, during 
gestation-weeks 1, 2 ,3, a unique dose of Vitamin C (100 mg/animal/dose) administered by 
gavages. The Animals in Group I received, after the same protocol, by gavages, physiological 
serum. In pregnant animals in day 21 and in non-pregnant animals, the lipid peroxides level 
was assessed, in the blood resulted from the puncture of retroorbitar sinus venous (Satoh, 
1978). The results were expressed in nmol/ml. As the parameters of the antioxidant defense, it 
was determined the hydrogen donor capacity (Janasewska, 2002). The experiments were 
made in Laboratory for oxidative stress exploration at the Department of Physiology, "Iuliu 
Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca. 
 
RESULTS 
 
 The results obtained after assessing the lipid peroxides showed a significant increase 
(p<0,0001) in Group II in the 21st day of pregnancy, at a medium value of 4,62± 0,32 
nmol/ml, as compared to Group I at a medium value of 1,87±0,12 nmol/ml. Lipid peroxides 
were significantly low (p<0,001) both in Group III (treated with Chitosan), at medium values 
of 2,26 ±0,48 nmol/ml and Group IV (treated with Vitamin C), at medium values of 2,22 
±0,56 nmol/ml (Fig. 1). The hydrogen donor capacity, an expression of the plasma total 
antioxidant capacity, presented significantly high values: Group II- 48,62 ±1,67% , as 
compared to Group I: 28,34±1,01 %. In Group III, hydrogen donors level was 29,5 ±2,83 %, 
significantly decreased values (p<0,0001), as compared to Group II; in Group IV (treated with 
Vitamin C): 42,9 ±3,70 %, values which are significantly low (p<0,01), as compared to Group 
II (Fig. 2). 
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Fig. 1 Variation of serum lipid peroxides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2 Variation of serum hydrogen donating ability 
 
DISCUSIONS 
 
The authors have highlighted significant increases of the lipid peroxidation, but also an 
increase of the antioxidant defense systems (hydrogen donor capacity) during gestation in 
rats. The results are also confirmed by the data in the literature (Olinescu, 1994), which shows 
the involvement of oxidative stress in "extreme" physiological states, like the pregnancy, 
physical effort, ageing and altitude adaptation. In pregnant women in their last trimester, but 
also in the new-born babies, there was highlighted an increased level of the lipid peroxides. If 
the pregnancy evolves with complications (toxemia, pre-eclampsia), the increase of ROS 
becomes significant, partly explaining the pathological alterations that accompany these 
processes (Shaarawy s.c., 1999). In the newborn babies with severe jaundice, the increase of 
the lipid peroxidation can produce severe lesions, irreversible (encephalopathy’s). 
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The high increase of ROS, evaluated by the authors by determining the lipid peroxides, 
is difficult to interpret in experimental animals, taking into account that, unlike human beings, 
they don't have pathological alterations-pre-eclampsia. The data in the literature (Buhinshi 
s.c., 2000) have shown that the transforming growth factor (TGF beta1) is a cytokine which 
mediates the cell proliferation, by a process which is associated with H2O2 synthesis, 
responsible of the oxidative stress induction. 
The oxidative stress induced by the ROS synthesis increase and/ or the decrease of the 
antioxidant protection systems is involved in the normal pregnancy or complicated with pre-
eclampsia. ROS and lipid peroxidation induced by them are involved in the pathogenetic 
mechanisms which produce pre-eclampsia, contributing to the installation of endothelial 
dysfunction. In pre-eclampsia the lipid peroxidation is more intense, the ROS level and the 
fibronectine increase, changes that are involved in the appearance of arterial hypertension, 
too. Experimental research has highlighted in rats an increase of superoxide-NADPH 
dependent synthesis in the ovary and uterus in early gestation. There were also evidence of 
superoxide radical’s synthesis activation and the decrease of SOD (Sugino s.c., 2000). 
Our researches have demonstrated that the administration of Chitosan inhibited ROS 
synthesis and increased serum antioxidant capacity. Vitamin C acted in the same way, but the 
alterations were less significant than in the case of Chitosan. 
In the pregnancy yellow body, the activity of CuZnSOD is significantly increased, 
parallel to the decrease of the lipoperoxides at this level. 
The vasomotricity of the umbilical artery is influenced by ROS, superoxide and 
peroxinitrite (Nemeth s.c., 2001). Determinations made in the human being showed that in the 
mother’s blood and in the one from the umbilical cord, the antioxidants with low molecular 
weight (uric acid, bilirubin) increase significantly. Antioxidant administration (Vitamin E, 
coenzyme Q10, vitamin C) decreases lipid peroxides production. The role of vitamin E in 
counteracting ROS effects is known, as well as the importance of its administration during 
pregnancy, preventing lipid peroxidation, inhibiting NADPH-oxidase activation and the 
inflammatory response (Dejica, 2001). 
Among the antioxidants, a less studied one is Chitosan, which has antioxidant effects (Je 
s.c., 2006), but also immunoadjuvant (Chen s.c., 2004), antitumoral (Qi s.c., 2007) and 
haemostatic effects. The data in the literature have shown that it has protective effects on the 
hepatotoxicity dependent on the lipoperoxidation, in experimental models of toxic hepatitis 
induced by C Cl4, by inhibiting malondialdehyde formation and increasing the content of 
hepatic hydrosulfur groups (Yan s.c., 2006). Other studies have shown that the scavenger 
activity of the hydroxil radical and superoxide anion increases with the increase of Chitosan 
concentration and the deacetylation degree (Pyo-Jam s.c., 2004) 
Vitamin C is in the first line of antioxidant defense in plasma, interacting directly with 
oxidant agents, being the most efficient protector against plasma lipid peroxidation (Dejica, 
2001). 
The observations on the favorable effect of natural or synthetic antioxidants in the 
protection of biological systems against the noxious effects of ROS (preventing the electron 
transfer from molecular oxygen to organics molecules, stabilizing ROS or inhibiting the 
reactions which generate ROS) are justifying their use in the prophylaxis or treatment of some 
pathological processes (Benzic, 2000; Muresan, 1977). 
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CONCLUSIONS 
 
The experiments made on Wistar female rats, during gestation, treated with antioxidants 
(Chitosan and Vitamin C) have shown the following: 
1. It was demonstrated a significant increase of the hydrogen donor capacity in the 21st 
day of gestation. 
2. It was demonstrated a significant increase of the hydrogen donor capacity in the 21st 
day of gestation, increase of the serum antioxidant capacity necessary for neutralizing ROS.  
3. The serum level of lipid peroxides has significantly decreased in pregnant animals 
treated with antioxidants (Chitosan and Vitamin C). 
4. The administration of antioxidants (Chitosan and Vitamin C) has increased serum 
antioxidant capacity, assessed by measuring the hydrogen donor capacity, in pregnant animals 
as compared to the control groups. 
 
BIBLIOGRAPHY 
 
1. Benzic IF, 2000, Evolution of antioxidant defence mechanisms, Eur. J. Nutr., 39, 53-63. 
2. Buhimschi IA, WB Kramar, CS Buhimsch, LP Thompson, LP Wiener, 2000, Reductase-oxidation (Redox) 
state regulation of matrix metaloproteinase activity in human fetal membranes, Am. J. Obstret. Gynecol., 
184, 458-464. 
3. Chen WR, M Korbelik, KE Bartels, 2004, Enhancement of laser cancer treatment by a chitosan-derived 
immunoadjuvant, Photochemistry and Photobiology, 190-195. 
4. Dejica D, 2000,  Stresul oxidativ in bolile interne, Casa Cartii de Stiinta,Cluj Napoca. 
5. Dejica D, 2001, Antioxidanti si terapia antioxidanta, Casa Cartii de Stiinta, Cluj Napoca.  
6. Janasewska A, G Bartos, 2002, Assay of total antioxidant capacity: comparision of four methods as to 
human blood plasma, Scand. J. Clin. Lab. Invest., 62, 231-236.  
7. Je JY, SK Kim, 2006, Reactive oxygen species scavenging activity of aminoderivatized chitosan with 
different degree of deacetylation, Bioorganic and Medicinal Chemistry, 14, 5989-5994. 
8. Muresan Adriana, 1977, Speciile reactive ale oxigenului in patologia clinica, Ed. Dacia, Cluj Napoca. 
9. Nemeth I, H Orvos, D Boda, 2001, Blood glutathione redox status in gestational hypertension, Free Radical. 
Biol. Med., 30, 712-721. 
10. Olinescu R, 1994, Radicalii liberi in fiziopatologia umana, Ed.Tehnica,Bucuresti. 
11. Pyo-Jam P, JY Je, SK Kim, 2004, Free radical scavenging activities of differently deacetylated chitosan 
using an ESR spectrometer, Carbohydrate Polymers, 55, 1, 17-22. 
12. Qi L, Z Xu, M Chen, 2007, In vtro and in vivo suppression of hepatocellular carcinoma growth by chitosan 
nanoparticles, Eur. J. Cancer, 43, 1, 184-193. 
13. Satoh K, 1978, Serum lipid peroxide in cerebrovacular disorders determined by a new colorimetric method, 
Clin. Chim. Acta, 90, 37-43. 
14. Shaarawy M, A Aref, E Salem, M Sheiba, 1999, Radical scavenging antioxidants in pre-eclampsia and 
eclampsia, Inter. J. Gynecol. Obstret.., 60, 123-128. 
15. Sugino N, M Nakata, S Kashida, 2000, Dereased superoxiddismutase expression and increased concentratin 
of lipid peroxide and prostaglandin F2α in the decidua of failed pregnancy, Mol. Hum. Reprod., 6, 642-647. 
16. Tanveer AK, KP Kok, 2003, J. Pharm. Pharmaceut Sci , 6, 1, 20-26. 
17. Zhang J, J Zeng, S Zhang, Y Wang, Y Wang, 2006,  Journal of Bioactive and Compatible Polymers, 21, 5, 
415-432. 
18. Yan Y, L Wanshun, H Baoqin, L Bing, F Chenwei, 2006, Protective effects of chitosan oligosaccharide and 
its derivatives against carbon tetrachloride-induced liver damage in mice, Hepatol Res., 35, 3, 178-184. 
